| |
| |
|
| Insider
Information: |
Taubert Jennifer L |
| Relationship: |
EVP, WWC. Innovative M... |
| City: |
New Brunswick |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
154,851 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$22,629,925 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
154,851 |
|
|
| Total
Value |
$22,629,925 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -8.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Johnson & Johnson |
JNJ |
EVP, WWC. Innovative M... |
2024-02-13 |
154,851 |
2019-02-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JNJ |
Johnson & Johnson |
EVP, WWC. Innovative Medicine |
• • – |
2024-02-13 |
4 |
D |
$157.85 |
$105,128 |
D/D |
(666) |
154,851 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WWC. Innovative Medicine |
• • – |
2024-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,302 |
155,517 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WWC. Innovative Medicine |
• • – |
2024-02-12 |
4 |
D |
$157.40 |
$2,109,632 |
D/D |
(13,403) |
154,215 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WWC. Innovative Medicine |
• • – |
2024-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,202 |
167,618 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2024-02-09 |
4 |
S |
$156.27 |
$9,281,969 |
D/D |
(59,397) |
141,416 |
0 |
% |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2024-02-09 |
4 |
OE |
$90.44 |
$5,371,865 |
D/D |
59,397 |
200,813 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2024-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,739 |
143,329 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2024-02-08 |
4 |
D |
$156.33 |
$299,059 |
D/D |
(1,913) |
141,416 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2023-02-13 |
4 |
D |
$162.01 |
$1,712,284 |
D/D |
(10,569) |
139,590 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
21,422 |
150,159 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2023-02-10 |
4 |
D |
$162.08 |
$208,921 |
D/D |
(1,289) |
128,737 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,570 |
130,026 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2022-11-22 |
4 |
S |
$176.78 |
$13,598,402 |
D/D |
(76,923) |
126,456 |
0 |
% |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2022-11-22 |
4 |
OE |
$72.54 |
$5,579,994 |
D/D |
76,923 |
203,379 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2022-02-15 |
4 |
D |
$165.89 |
$1,466,633 |
D/D |
(8,841) |
126,456 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,064 |
135,297 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2022-02-14 |
4 |
D |
$168.85 |
$200,932 |
D/D |
(1,190) |
117,233 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,297 |
118,423 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2021-02-12 |
4 |
D |
$165.55 |
$1,004,061 |
D/D |
(6,065) |
115,126 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,606 |
121,191 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2020-02-13 |
4 |
D |
$150.46 |
$1,237,985 |
D/D |
(8,228) |
107,585 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2020-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,084 |
115,813 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2020-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
48,312 |
123,450 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2020-02-03 |
4 |
D |
$149.32 |
$3,542,020 |
D/D |
(23,721) |
99,729 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, WW Chair, Pharmaceuticals |
• • – |
2019-02-11 |
4 |
D |
$131.94 |
$822,778 |
D/D |
(6,236) |
73,751 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
